Thread by @DavidCranmerUn1

740 Park Avenue - Wikipedia

Hedge fund manager David Ganek paid $19 million for the childhood duplex home of Jacqueline Kennedy Onassis in 2005. en.wikipedia.org/wiki/740_Park_…

Before a November 2010 FBI raid on its offices, most people probably hadn't heard of Level Global Holdings - a Connecticut hedge fund run by SAC Capital alum, David Ganek.

David Ganek paid $19 million for his apartment in 740 Park Avenue, of which previous tenants include

former ITT chairman Rand Arasko; John V. Bouvier III, his wife Janet and their daughter Jacqueline (Kennedy Onassis). Also, John Thain and Steve Schwarzman also live in the building.

Newton D. Baker House, also known as Jacqueline Kennedy House, is a historic house at

3017 N Street NW in Washington, D.C. Built in 1794, it was home of Newton D. Baker, who was Secretary of War, during 1916–1920, while "he presided over America's mass mobilization of men and material in World War I. After the assassination of president John F. Kennedy in 1963,

Jacqueline Kennedy purchased the house and lived here for about a year.

In 1965, Michael Whitney Straight purchased the home for $200,000, from Kennedy when she moved to New York City. While living in the home, Straight married his second wife, Nina G. Auchincloss Steers in

1974. Nina was the daughter of Nina Gore and Hugh D. Auchincloss. She was the half-sister of writer Gore Vidal and coincidentally, a stepsister of Jacqueline Kennedy Onassis.

While a student at Trinity College, Cambridge in the mid-1930s, Straight became a Communist Party

member and a part of an intellectual secret society known as the Cambridge Apostles. Straight worked for the Soviet Union as part of a spy ring whose members included Donald Maclean, Guy Burgess, Kim Philby and KGB recruiter Anthony Blunt.

However, in 1963, in response to an

offer of government employment in Washington, D.C., Straight faced a background check, and decided voluntarily to inform family friend and presidential special assistant Arthur M. Schlesinger, Jr. about his communist connections at Cambridge.

Like Guy Burgess, Blunt was known

to be homosexual, the practice of which was a criminal offence at the time in Britain. Both were members of the Cambridge Apostles (also known as the Conversazione Society), a clandestine Cambridge discussion group of 12 undergraduates, mostly from Trinity and King's Colleges

who considered themselves to be the brightest minds. Through the Apostles, he met the future poet Julian Bell (son of Vanessa Bell) and took him as a lover. Many others were homosexual and also Marxist at that time. Amongst other members were Victor Rothschild and the American

Michael Whitney Straight, the latter also later suspected of being part of the Cambridge spy ring. Rothschild later worked for MI5 and also gave Blunt £100 to purchase the painting Eliezar and Rebecca by Nicolas Poussin.

In 1935 Julian Bell went to China, to a position teaching

English at Wuhan University. He wrote letters describing his relationship with a married lover, K. - Ling Shuhua, the wife of Professor Chen Yuan (better known by his penname, Chen Xiying). The identity of 'K' became a sensitive issue when the Chinese-British novelist Hong Ying

published a fictionalised account, K: The Art of Love in 1999.

Wuhan University has collaborated with Duke University and the city of Kunshan to establish Duke Kunshan University.

Dr. Chenkai Wu was appointed as the Associate Director of Graduate Studies, MSc of

Global Health on 31 Oct 2018.

Dr. Wu is an Assistant Professor in the Global Health Research Center at Duke Kunshan University and was a faculty in the Department of Epidemiology at New York Medical College. His current research focuses on (i) measurement, epidemiology, and

clinical implications of frailty, (ii) prevention of cardiovascular morbidity and mortality, and (iii) quantification and risk factors for healthy aging. Dr. Wu has published over 10 peer-reviewed papers in the fields of epidemiology, gerontology, and cardiovascular disease.

Shuang Sarah Wu at Pfizer had thirty-one LinkedIn profiles created in her name, and she was employed by Biogen during a key Biogen SuperSpreader Conference in February 2020 which focused on using AI for drug discovery.

Jordan Walker and his supposed boss at Pfizer, Shuang Sarah Wu, actually played key roles for Boston Consulting Group and Biogen at this
conference.

This hidden past of Shuang Sarah Wu is especially interesting since the mystery woman who disappears to China after the Biogen twitter.com/i/web/status/1…

SuperSpreader Conference is still unknown. The mystery woman fleeing the Biogen Conference may or may not be Shuang Sarah Wu, but our researchers are actively trying to run this lead down.

Mikael Dolsten, M.D., Ph.D.
Chief Scientific Officer and President, Worldwide Research,

Development and Medical of Pfizer Inc.

Mikael Dolsten is a member of the Board of Overseers for the Scripps Research Institute and a Foreign Member of The Royal Swedish Academy of Engineering Sciences. Since 2014, Mikael had co-chaired the Accelerating Medicine Partnership with

National Institutes of Health (NIH) Director, Francis S. Collins, and now with Acting Director, Lawrence Tabak. Mikael advised the Obama Administration on regulatory and drug development issues as well as then Vice President Biden’s Cancer Moonshot Initiative to accelerate

cancer research.

Dolsten was appointed President of R&D at the American Pharma Wyeth 2008. Dolsten joined Pfizer in 2009 during the acquisition of Wyeth as Head of BioTherapeutics.

Dolsten has been part of leading the Pfizer Covid vaccine effort in 2020.

Dolsten is on an advisory board of the Pharmaceutical Research and Manufacturers of America, board member of Research America (PhRMA) and board member of the public company Karyopharm Therapeutics in Boston.

Ramona Sequeira, President of Takeda’s Global Portfolio Division, is

chairman of the PhRMA board. Vasant (Vas) Narasimhan, M.D., CEO of Novartis, is chairman-elect and Daniel O'Day, Chairman of the Board of Directors and CEO of Gilead Sciences, is board treasurer.

Daniel O'Day joined Gilead Sciences in March 2019 as Chairman of the Board of

Directors and Chief Executive Officer.
Prior to Gilead, Daniel served as the Chief Executive Officer of Roche Pharmaceuticals.

Daniel O'Day holds a bachelor's degree in biology from Georgetown University and an MBA from Columbia University in New York. He currently serves on the

board of directors for the Pharmaceutical Research and Manufacturers of America organization and Galapagos NV.

Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen

and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The outgoing CEO is the Dutchman Onno van de Stolpe and his replacement is Paul Stoffels, effective April 1, 2022.

Galapagos Genomics NV was founded in 1999 as a joint venture between

Crucell and Tibotec.

Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell based in Leiden and placed it in their pharmaceutical

division.

Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening at Janssen Biotech in Leiden, Netherlands. The vaccine stands out because it is the first single-shot vaccine against COVID-19 that was

developed during the COVID-19 pandemic.

Tibotec was a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged

into its Janssen Pharmaceuticals division in 2002.

In 1994, Rudi Pauwels of the Rega Institute for Medical Research founded Tibotec, together with his wife Carine Claeys, and their first co-workers Marie-Pierre de Béthune, Kurt Hertogs, and Hilde Azijn. In 1995 Paul

Stoffels (Janssen Pharmaceuticals) joined Tibotec. The company was acquired by Johnson & Johnson in April 2002.

Paul Stoffels worked for four years as a physician and researcher of HIV/AIDS and tropical diseases in Africa, where he met Peter Piot.

Sir Peter Karel, Baron Piot,

KCMG, FRCP, FFPH, FMedSci (born 17 February 1949) is a Belgian-British microbiologist known for his research into Ebola and AIDS.

After helping discover the Ebola virus in 1976 and leading efforts to contain the first-ever recorded Ebola epidemic that same year, “piss” Piot

became a pioneering researcher into AIDS. He has held key positions in the United Nations and World Health Organization involving AIDS research and management.

Piot has received the majority of the credit for discovering Ebola, since in 1976, it was claimed he was the one to

receive blood samples while working in a lab at the Institute for Tropical Medicine in Antwerp, Belgium. The samples were once claimed to be originally sent by Dr. Jean-Jacques Muyembe-Tamfum, a Congolese doctor who obtained the blood samples from those sickened with a mysterious

disease in then-Zaire, later discovered to be Ebola.

Jean-Jacques Muyembe is a Congolese microbiologist. He is the general director of the Democratic Republic of the Congo Institut National pour la Recherche Biomedicale (INRB). He was part of team at the Yambuku Catholic Mission

Hospital that investigated the first Ebola outbreak, and was part of the effort that discovered Ebola as a new disease, although his exact role is still subject to controversy.

Muyembe was described by The Lancet as Africa's Ebola hunter.

In 2009, Jean-Jacques Muyembe demonstrated that the Ebola outbreaks in the DRC were due to fruit bat exposure.

In 2014, Muyembe was appointed by Director General Margaret Chan to the WHO Advisory Group on the Ebola Virus Disease Response, co-chaired by Sam Zaramba and David L. Heymann.

Heymann was the World Health Organization's assistant director-general for health, security, and

environment, and the representative of the director-general for polio eradication. Previously, from 1998–2003, he was executive director of the WHO Communicable Diseases Cluster and from October 1995 to July 1998 he was director of the WHO Programme on Emerging and other

Communicable Diseases. Prior to this, he was the chief of research activities in the WHO Global Programme on AIDS.

Heymann was also chairman of the Strategic Advisory Group of Hilleman Laboratories.

Hilleman Laboratories is a Delhi-based vaccine research organization. The firm

is an equal-joint venture between US drug maker Merck & Co Inc and British charitable foundation Wellcome Trust. The research firm is named in the honour of Dr. Maurice Ralph Hilleman (1919–2005).

In 1957, Hilleman joined Merck & Co. (Kenilworth, New Jersey), as head of its new virus and cell biology research department in West Point, Pennsylvania.

Hilleman was among the first to recognize that a 1957 outbreak of influenza in Hong Kong could become a huge pandemic.

In 1968, during the Hong Kong flu pandemic, Hilleman and his team also played a key role in developing a vaccine, and nine million doses became available in 4 months.

Hilleman was one of the vaccine pioneers to warn about the possibility that simian viruses might contaminate

vaccines. The best-known of these viruses is SV40, a viral contaminant of the polio vaccine, whose discovery led to the recall of Jonas Salk's vaccine in 1961 and its replacement with Albert Sabin's oral vaccine.

In 1963, Salk founded the Salk Institute for Biological Studies in

La Jolla, California, which is today a center for medical and scientific research. He continued to conduct research and publish books in his later years, focusing in his last years on the search for a vaccine against HIV.

In the late 1980s, while a graduate student researcher at

the Salk Institute for Biological Studies in San Diego, California, Robert Malone conducted studies on messenger ribonucleic acid (mRNA) technology. twitter.com/i/web/status/1…